Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Ballou

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|October 9, 1999
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccineA Lalvani, P Moris, G Voss, et al.
Vaccine|June 2, 1998
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvantsT P Le, L W Church, G Corradin, et al.
The Journal of Infectious Diseases|April 1, 1997
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challengeL W Church, T P Le, J P Bryan, et al.
The Journal of Infectious Diseases|August 1, 1996
Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomesD G Heppner, D M Gordon, M Gross, et al.
The American Journal of Tropical Medicine and Hygiene|January 14, 1999
Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19)A Gozalo, C Lucas, M Cachay, et al.
Lancet (London, England)|December 19, 2001
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialK A Bojang, P J Milligan, M Pinder, et al.
The Journal of Infectious Diseases|November 7, 1998
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccineJ A Stoute, K E Kester, U Krzych, et al.
Journal of Clinical Microbiology|July 28, 2001
Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field studyJ R Forney, A J Magill, C Wongsrichanalai, et al.
Vaccine|June 1, 1996
Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of KenyaJ A Sherwood, R S Copeland, K A Taylor, et al.
Infection and Immunity|September 1, 1996
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malariaJ A Tine, D E Lanar, D M Smith, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|October 9, 1999
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccineA Lalvani, P Moris, G Voss, et al.
Vaccine|June 2, 1998
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvantsT P Le, L W Church, G Corradin, et al.
The Journal of Infectious Diseases|April 1, 1997
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challengeL W Church, T P Le, J P Bryan, et al.
The Journal of Infectious Diseases|August 1, 1996
Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomesD G Heppner, D M Gordon, M Gross, et al.
The American Journal of Tropical Medicine and Hygiene|January 14, 1999
Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19)A Gozalo, C Lucas, M Cachay, et al.
Lancet (London, England)|December 19, 2001
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialK A Bojang, P J Milligan, M Pinder, et al.
The Journal of Infectious Diseases|November 7, 1998
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccineJ A Stoute, K E Kester, U Krzych, et al.
Journal of Clinical Microbiology|July 28, 2001
Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field studyJ R Forney, A J Magill, C Wongsrichanalai, et al.
Vaccine|June 1, 1996
Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of KenyaJ A Sherwood, R S Copeland, K A Taylor, et al.
Infection and Immunity|September 1, 1996
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malariaJ A Tine, D E Lanar, D M Smith, et al.
Pageof 10